17-alpha-hydroxyprogesterone


Also found in: Wikipedia.

17-al·pha-hy·drox·y·pro·ges·ter·one

(-ăl′fə-hī-drŏk′sē-prō-jĕs′tə-rōn′)
n.
A compound produced by the adrenal glands and often used therapeutically as a progestogen when such a steroid is needed for parenteral administration.
References in periodicals archive ?
In this case, the FDA had approved a compounded therapy 17-alpha-hydroxyprogesterone caproate (17P) to prevent preterm birth.
He pinpointed Takeover Target because of his ban for failing a test for 17-alpha-hydroxyprogesterone hexanoate, or HPC, a steroid that can build muscle.
The new treatment, weekly shots of a hormone called 17-alpha-hydroxyprogesterone caproate, or 17P, were started at sixteen to eighteen weeks of pregnancy and stopped at thirty-six weeks.
Food and Drug Administration ("FDA") issued an approvable letter to Adeza Biomedical for their candidate for prevention of recurrent preterm birth, the synthetic progestogen 17-alpha-hydroxyprogesterone caproate (trademarked "Gestiva").
CHICAGO -- The effect of 17-alpha-hydroxyprogesterone caproate on preterm birth varies depending on the presence or absence of cerclage in high-risk women, according to a planned secondary analysis of the Vaginal Ultrasound Cerclage Trial.
Food and Drug Administration ("FDA") has issued an approvable letter to Adeza Biomedical for their synthetic progestogen, 17-alpha-hydroxyprogesterone caproate (trademarked "Gestiva"), Adeza's candidate for prevention of recurrent preterm birth.
We are not surprised the FDA would require additional animal studies of 17-alpha-hydroxyprogesterone caproate given the high level of fetal toxicity of this synthetic progestin in a previously conducted study in monkeys.
HONG KONG The Hong Kong Jockey Club yesterday announced that independent analysis of a blood sample taken from top Australian sprinter Takeover Target had confirmed the presence of locally banned substance 17-alpha-hydroxyprogesterone hexanoate, writes Jon Lees.